PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...
People whose biological mothers had diabetes during pregnancy are more likely to develop MS as adults, according to a study ...
January might offer a new year reset, but chronic illness demands us to move forward and bring what we’ve learned, says ...
Elsa Mendoza is the mother of Heisman Trophy winner and newly crowned CFP National Champion Fernando Mendoza, the quarterback ...
ScienceAlert on MSN
Multiple sclerosis may have two distinct subtypes, scientists discover
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...
Multiple sclerosis is a disease in which the immune system erroneously attacks a protective insulation that surrounds neurons ...
VANCOUVER, BC / ACCESS Newswire / January 21, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report final results from a preclinical pig study ...
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback